FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors led by Charles Pollack, Jr. MD, FACEP
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), is pleased to announce the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board (“SAB”). read more

Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention

Panel to Feature Discussion About Creating a Winning Culture in the Biotech Industry
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that Executive Co-Chairman and Chief Executive Officer, Dr. Raza Bokhari, will be featured in the 2019 BIO International Convention’s panel presentation, “Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots,” on June 4 in Philadelphia, PA. read more

FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

Company Also Reports Q1 2019 Financial Results
C.HUGE, FSD Pharma, cannabis, pot

The Board of Directors of FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), unanimously voted Raza Bokhari, M.D., Executive Co-Chairman of the Board, as permanent Chief Executive Officer. Dr. Bokhari has served as interim CEO of the Company since February. read more

FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) would like to congratulate High Tide Inc. (CSE: HITI) (OTCQB: HITIF) (FRA: 2LY) (“High Tide”) on the recent announcement from Alberta Gaming, Liquor and Cannabis lifting the moratorium on issuing cannabis licenses and accepting license applications. The announcement is an encouraging sign of steadily improving cannabis supply levels in Alberta and is a positive step for companies like High Tide that have numerous stores ready and waiting to retail cannabis products. read more

Rockridge Announces the Appointment of Grant Ewing as Chief Executive Officer of the Company

Rockridge Resources Ltd. (TSX-V: ROCK) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce the appointment of Grant Ewing as Chief Executive Officer of the Company. Grant Ewing is a professional geologist with over 25 years of experience in the mineral industry and the last 10+ years in senior executive roles. His extensive knowledge base covers the entire mine development cycle, from early stage exploration through to production, in several different commodities. Strong merger and acquisitions, corporate development, and capital markets knowledge complement Mr. Ewing’s mineral industry experience. read more

NexGen Intersects High-Grade Mineralization in all Twenty A2 and A3 Targets from the 2019 Feasibility Stage Drilling Program

T.NXE, NexGen, uranium
Figure 1: Arrow Deposit Drill Hole Locations (CNW Group/NexGen Energy Ltd.)

NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE, NYSE MKT: NXE) is pleased to report radioactivity for an additional twenty holes comprising 7,969.5 m from the Company’s Feasibility stage drilling program at our 100% owned, Rook I property in the Athabasca Basin Saskatchewan. read more

Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment of pharmaceutical industry leader, Edward J. Brennan, Jr., M.D., FACS, as President of its biosciences division. Dr. Brennan has more than 25 years’ experience in leadership roles at major pharmaceutical companies and clinical research organizations. read more

Aben Announces Ambitious Exploration Plans for Justin Gold Project in the Yukon and Forrest Kerr Gold Project in BC’s Golden Triangle Region

Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) is pleased to provide an update on the Company’s plans for the coming 2019 drill season at the 100% owned 7,400-hectare Justin Gold Project in the Yukon and the 23,000-hectare Forrest Kerr Gold Project in the Golden Triangle region of British Columbia. This year, the Company plans to extend its drilling season one month by initiating a 2000-meter drill program at the Justin Gold Project commencing in early June. This program will entail 1350 meters of diamond drilling and 600 meters of Rotary Air Blast drilling (“RAB”), along with prospect generating field work. This program should take 3-4 weeks to complete which will coincide with the commencement of the Forrest Kerr Project 2019 drill program at the end of June. The Forrest Kerr drill program is on track to complete a planned 5000 meters but has the ability to add to the size and scope of the program if results warrant. Aben is well funded and looks forward to the onset of exploration on both of these high-quality Canada-based gold projects. read more